Cbd Global Sciences Inc
CNSX:CBDN
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| CA |
C
|
Cbd Global Sciences Inc
CNSX:CBDN
|
1.5m CAD |
Loading...
|
|
| IN |
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
4.2T INR |
Loading...
|
|
| CH |
S
|
Sandoz Group AG
SIX:SDZ
|
29.9B CHF |
Loading...
|
|
| US |
|
Dupont De Nemours Inc
NYSE:DD
|
20.8B USD |
Loading...
|
|
| CN |
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
90.9B CNY |
Loading...
|
|
| CN |
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
47B CNY |
Loading...
|
|
| JP |
|
Sumitomo Pharma Co Ltd
TSE:4506
|
931.6B JPY |
Loading...
|
|
| UK |
|
Croda International PLC
LSE:CRDA
|
4.4B GBP |
Loading...
|
|
| US |
|
Balchem Corp
NASDAQ:BCPC
|
5.8B USD |
Loading...
|
|
| CN |
|
Hebei Changshan Biochemical Pharmaceutical Co Ltd
SZSE:300255
|
39.4B CNY |
Loading...
|
|
| CN |
C
|
Changchun High & New Technology Industries Group Inc
SZSE:000661
|
36.1B CNY |
Loading...
|
Market Distribution
| Min | -10 058.3% |
| 30th Percentile | 20.4% |
| Median | 33.6% |
| 70th Percentile | 50.5% |
| Max | 717.4% |
Other Profitability Ratios
Cbd Global Sciences Inc
Glance View
Cbd Global Sciences, Inc. engages in business of producing and selling industrial hemp derived cannabidiol infused consumable and topical products. The company is headquartered in Calgary, Alberta. The company went IPO on 2019-10-29. The firm is engaged in the business of producing and selling industrial hemp derived CBD infused consumable and topical products, including but not limited to CBD oil tincture drops, CBD hydration beverages, and CBD topicals. The company markets and sells its own brand of CBD oil and byproducts under the Aethics and CannaOil brands (Products), which includes CBD Oil tinctures (liquid products), CBD capsules, CBD topicals, hydration products and confectionary products. Its hemp-derived CBD extracts are sold through distributors, brick and mortar retailers and online. The Company, through its wholly owned subsidiaries, Global Sciences Holdings, Resinosa LLC and Legacy Distribution Group, is delivering CBD products both in a retail and e-commerce formats. Its subsidiaries include Strasburg Pharms, LLC, Global NV Corp., CannaOil, Inc., SMBT, LLC, Global Sciences IP, LLC and Energy Unleased LLC, among others.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
Over the last 2 years, Cbd Global Sciences Inc’s Gross Margin has increased from -39.1% to 72.2%. During this period, it reached a low of -950.7% on Jun 30, 2021 and a high of 72.2% on Oct 30, 2022.